Literature DB >> 14531045

Significance of non-presynaptic SPECT tracer methods in Parkinson's disease.

Klaus L Leenders1.   

Abstract

Tropane-related tracers for SPECT and PET scanning have shown their value in assessing the in vivo striatal presynaptic status of the dopaminergic neurotransmitter system in man. Previously, there were a few other tracers suggested to be useful in the study of in vivo brain biochemistry in humans, particularly in patients afflicted with Parkinson's disease (PD) or parkinsonian syndromes. We summarize the work concerning the two main tracers applied in that context using single photon emission tomography (SPECT) scanning in patients with PD: IBZM and HMPAO. IBZM binds specifically to striatal dopamine D(2) receptors and HMPAO uptake is a measure of cerebral tissue perfusion. Copyright 2003 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14531045     DOI: 10.1002/mds.10577

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  5 in total

1.  In vitro and initial in vivo evaluation of (68)Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells.

Authors:  Carmen Wängler; Dina Nada; Georg Höfner; Simone Maschauer; Björn Wängler; Stephan Schneider; Esther Schirrmacher; Klaus T Wanner; Ralf Schirrmacher; Olaf Prante
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

Review 2.  Manganese and Parkinson's disease: a critical review and new findings.

Authors:  Tomás R Guilarte
Journal:  Environ Health Perspect       Date:  2010-04-19       Impact factor: 9.031

3.  Dual-tracer PET using generalized factor analysis of dynamic sequences.

Authors:  Georges El Fakhri; Cathryn M Trott; Arkadiusz Sitek; Ali Bonab; Nathaniel M Alpert
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

Review 4.  Manganese-Induced Parkinsonism and Parkinson's Disease: Shared and Distinguishable Features.

Authors:  Gunnar F Kwakye; Monica M B Paoliello; Somshuvra Mukhopadhyay; Aaron B Bowman; Michael Aschner
Journal:  Int J Environ Res Public Health       Date:  2015-07-06       Impact factor: 3.390

5.  Recent progress of imaging agents for Parkinson's disease.

Authors:  Xiaoai Wu; Huawei Cai; Ran Ge; Lin Li; Zhiyun Jia
Journal:  Curr Neuropharmacol       Date:  2014-12       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.